Shanghai, China

Xinjian Chen

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Chinese Academy of Sciences, Topharman Shanghai Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xinjian Chen. Retrieved from https://idiyas.com/inventor/xinjian-chen-k6762qxp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Xinjian Chen

Introduction

Xinjian Chen is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

Xinjian Chen holds a patent for "Tetrahydroprotoberberine compounds, the synthetic method and the use thereof." This invention relates to tetrahydroprotoberberines of a specific formula and their physiologically acceptable salts. The compounds are intended for use in preparing pharmaceutical compositions aimed at treating medical disorders that can be addressed with dopamine receptor ligands, such as schizophrenia.

Career Highlights

Throughout his career, Xinjian Chen has worked with esteemed organizations, including the Chinese Academy of Sciences and Topharman Shanghai Co., Ltd. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Xinjian Chen has collaborated with notable colleagues, including Jianfeng Li and Aixiang Liu. These partnerships have likely enriched his research and innovation efforts.

Conclusion

Xinjian Chen's work in the field of pharmaceuticals, particularly with his patented compounds, showcases his dedication to advancing medical science. His contributions have the potential to impact the treatment of significant medical disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…